SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-15-002949
Filing Date
2015-03-30
Accepted
2015-03-30 16:58:24
Documents
5
Period of Report
2015-05-14
Effectiveness Date
2015-03-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2223848zdef14a.htm DEF 14A 326015
2 G974952.JPG g974952.jpg GRAPHIC 7167
3 G326605.JPG g326605.jpg GRAPHIC 9927
4 G73592BGI001.GIF g73592bgi001.gif GRAPHIC 62603
5 G73592BGI002.GIF g73592bgi002.gif GRAPHIC 54209
  Complete submission text file 0001047469-15-002949.txt   512241
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36399 | Film No.: 15735200
SIC: 2834 Pharmaceutical Preparations